ArticleMedicine2017

Erratum: Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs: Erratum.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.